Jessica Parent
Nurse Practitioner · Somersworth, NHNPI 1497531792
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 43.5% of the total. 2025 is the largest year on record at $674, more than ten times the $48 reported in 2023. Among nurse practitioner clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$469
- Gilead$153
- Vanda Pharmaceuticals Inc.$79
- Baxter Healthcare$61
- Novo Nordisk$38
- Daiichi Sankyo Inc.$28
- plus $251 from 13 others
What the payments were for
- Food & beverage$1,079100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $469 |
| Gilead | 7 | $153 |
| Vanda Pharmaceuticals Inc. | 2 | $79 |
| Baxter Healthcare | 1 | $61 |
| Novo Nordisk | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Pfizer | 2 | $28 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Merck | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Braeburn Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
How this compares
$1,079 in reported general payments places this provider in the 90th percentile of 714 nurse practitioner providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $46,169 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $15,574 |
| TrulicityDulaglutide | 11 | $13,982 |
| MounjaroTirzepatide | 14 | $13,552 |
| JardianceEmpagliflozin | 12 | $10,926 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $2,128 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 45 | $1,547 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $1,483 |
| Duloxetine Hcl | 23 | $1,312 |
| Methylphenidate Hcl Er (Cd)Methylphenidate Hcl | 13 | $1,309 |
| Gabapentin | 43 | $750 |
| Atorvastatin Calcium | 59 | $530 |
| Hydroxyzine Hcl | 26 | $429 |
| Levothyroxine Sodium | 48 | $390 |
| Tizanidine Hcl | 28 | $327 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $38 | $46,16937 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $19 | $27,53425 claims |
| Boehringer IngelheimJardiance | $18 | $10,92612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 714 nurse practitioner providers in New Hampshire.
Other nurse practitioner in Somersworth
- Michael RobustelliSomersworth$17K
- Sonya AlyeaSomersworth$6K
- Shelby MenardSomersworth$4K
- Julia MikulichSomersworth$588
- Jessica St JeanPelham$302K
- Denise McGrathLebanon$7K
- Lisa WilliamsBedford$7K
- Shareen LucasPortsmouth$7K
- Jessica PollackConcord$5K
- Jennifer GriffinNashua$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.